Search
Search Results
-
Lipoprotein(a): what clinicians need to know
141PDF: 239HTML: 16 -
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
513PDF: 1587Supplementary: 196Appendix: 141HTML: 14 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
694PDF: 163Supplementary: 133Appendix: 104HTML: 1 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
56PDF: 97Supplementary: 61HTML: 6 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
698PDF: 154Supplementary: 140Appendix: 103HTML: 6 -
Applicability of obesity clinical practice guidelines in low- and middle-income countries
874PDF: 462Appendix: 130HTML: 1 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1013pdf: 204Supplementary Material: 35HTML: 76 -
Epidemiology of peripartum cardiomyopathy in Africa
2119PDF: 468HTML: 36 -
-
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
3226PDF: 445Appendix: 360HTML: 20 -
Modulation of cardiac metabolism in heart failure
2273PDF: 975HTML: 4 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
1825PDF: 483SUPPLEMENTARY MATERIAL: 291GRAPHICAL ABSTRACT: 258HTML: 4 -
-
Safety and efficacy of left atrial appendage closure in cancer versus non-cancer patients: a systematic review and meta-analysis
1055PDF: 225Supplementary: 150HTML: 66 -
The association of iron deficiency with right ventricular dysfunction in Africans with heart failure
2160PDF: 365Appendix B: 424Appendix A: 312HTML: 1 -